论文部分内容阅读
目的研究同型半胱氨酸在原发性高血压中的检测意义,为今后原发性高血压疗效提升及疗效判定提供参考。方法将132例原发性高血压患者按治疗方法不同随机分成对照组和研究组,根据血压级别将所有患者进行划分,观察治疗前三个级别患者同型半胱氨酸水平及治疗前后同型半胱氨酸水平。结果血压级别越高,血浆同型半胱氨酸水平越高,3级患者最高,且3级中高Hcy血症比重(100.00)最高;治疗后,两组患者血浆同型半胱氨酸水平均明显下降,研究组患者同型半胱氨酸水平较对照组低。P均<0.05。结论同型半胱氨酸可作为原发性高血压病情评估指标,可用于疗效评估,指导治疗。
Objective To investigate the significance of homocysteine in the detection of essential hypertension and to provide reference for improving the therapeutic effect and the therapeutic effect of essential hypertension in the future. Methods A total of 132 patients with essential hypertension were randomly divided into control group and study group according to different treatment methods. All patients were divided according to blood pressure level. Homocysteine level and homocysteine level before and after treatment were observed. Amino acid levels. Results The higher the blood pressure level, the higher the plasma homocysteine level, the highest in the third grade patients, and the highest in the third grade high homocysteinemia (100.00). After treatment, plasma homocysteine level decreased significantly in both groups , The study group patients with homocysteine levels lower than the control group. P <0.05. Conclusion Homocysteine can be used as an index to evaluate the condition of essential hypertension, which can be used to evaluate the curative effect and guide the treatment.